← FDA Drug Approvals (Drugs@FDA)
FULVESTRANT
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2019-08-22
Drug application
- FDA Application #
ANDA205871- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FULVESTRANT
- Generic name
- Fulvestrant
- Active ingredients
- FULVESTRANT
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR
- Marketing status
- Prescription
- Sponsor
- SAGENT PHARMS INC
- First approval
- 2019-08-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown